| A comprehensive overview of exosomes as drug delivery vehicles—endogenous nanocarriers for targeted cancer therapy KB Johnsen, JM Gudbergsson, MN Skov, L Pilgaard, T Moos, M Duroux Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1846 (1), 75-87, 2014 | 739 | 2014 |
| What is the blood concentration of extracellular vesicles? Implications for the use of extracellular vesicles as blood-borne biomarkers of cancer KB Johnsen, JM Gudbergsson, TL Andresen, JB Simonsen Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1871 (1), 109-116, 2019 | 199 | 2019 |
| Evaluation of electroporation-induced adverse effects on adipose-derived stem cell exosomes KB Johnsen, JM Gudbergsson, MN Skov, G Christiansen, L Gurevich, ... Cytotechnology 68, 2125-2138, 2016 | 176 | 2016 |
| Systematic review of factors influencing extracellular vesicle yield from cell cultures JM Gudbergsson, KB Johnsen, MN Skov, M Duroux Cytotechnology 68, 579-592, 2016 | 130 | 2016 |
| Systematic review of targeted extracellular vesicles for drug delivery–Considerations on methodological and biological heterogeneity JM Gudbergsson, K Jønsson, JB Simonsen, KB Johnsen Journal of Controlled Release, 2019 | 117 | 2019 |
| Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches JA Welsh, DCI Goberdhan, L O'Driscoll, EI Buzas, C Blenkiron, ... Journal of extracellular vesicles 13 (2), e12404, 2024 | 81 | 2024 |
| On the use of liposome controls in studies investigating the clinical potential of extracellular vesicle-based drug delivery systems–A commentary KB Johnsen, JM Gudbergsson, M Duroux, T Moos, TL Andresen, ... Journal of controlled release 269, 10-14, 2018 | 80 | 2018 |
| Exosomes and autophagy: rekindling the vesicular waste hypothesis JM Gudbergsson, KB Johnsen Journal of cell communication and signaling 13 (4), 443-450, 2019 | 68 | 2019 |
| A tumorsphere model of glioblastoma multiforme with intratumoral heterogeneity for quantitative analysis of cellular migration and drug response JM Gudbergsson, S Kostrikov, KB Johnsen, FP Fliedner, CB Stolberg, ... Experimental Cell Research 379 (1), 73-82, 2019 | 19 | 2019 |
| Conventional Treatment of Glioblastoma Reveals Persistent CD44+ Subpopulations JM Gudbergsson, E Christensen, S Kostrikov, T Moos, M Duroux, A Kjær, ... Molecular neurobiology 57, 3943-3955, 2020 | 14 | 2020 |
| Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture in brain tumors S Kostrikov, KB Johnsen, TH Braunstein, JM Gudbergsson, FP Fliedner, ... Communications biology 4 (1), 815, 2021 | 13 | 2021 |
| Cripto-1 localizes to dynamic and shed filopodia associated with cellular migration in glioblastoma cells JM Gudbergsson, M Duroux European Journal of Cell Biology 98 (5-8), 151044, 2019 | 7 | 2019 |
| Extracellular vesicles for targeted drug delivery: triumphs and challenges JM Gudbergsson Future medicinal chemistry 12 (14), 1285-1287, 2020 | 6 | 2020 |
| An evaluation of different Cripto‐1 antibodies and their variable results JM Gudbergsson, M Duroux Journal of Cellular Biochemistry, 2019 | 5 | 2019 |
| Transport of transferrin receptor-targeted antibodies through the blood-brain barrier for drug Delivery to the brain T Moos, JM Gudbergsson, KB Johnsen Drug Delivery to the Brain: Physiological Concepts, Methodologies and …, 2022 | 4 | 2022 |
| Extracellular vesicles from mesenchymal stem cells and their potential in tumor therapy JM Gudbergsson, M Duroux Mesenchymal Stromal Cells as Tumor Stromal Modulators, 521-549, 2017 | 1 | 2017 |
| Organized by ISEV and ISEV-Americas S General, C Théry | 1 | 2015 |
| Remodeling of the brain angioarchitecture in experimental chronic neurodegeneration MS Thomsen, S Kostrikov, LJ Routhe, KB Johnsen, SS Helgudottir, ... bioRxiv, 2024.04. 15.589475, 2024 | | 2024 |
| Understanding Glioblastoma Stem-Like Cells in Quest of a Target to Direct Treatment JM Gudbergsson Aalborg Universitetsforlag, 2020 | | 2020 |
| Development and characterization of a panel of orthotopic glioblastoma multiforme (GBM) patient-derived xenograft (PDX) mouse models for drug efficacy evaluation CH Nielsen, MZ Alfsen, MJ Wick, M Rundle, JM Gudbergsson, ... Cancer Research 79 (13_Supplement), 89-89, 2019 | | 2019 |
